Virus-Like Particle Market Poised for Robust Growth Driven by Versatile and Safe Vaccine Platform
-
Virus-Like Particles (VLPs) Market is expected to reach $9.8 billion by 2031, growing at a CAGR of 7.85%
-
VLPs are protein structures that mimic viruses but don't contain genetic material, making them safe and versatile for vaccines
-
Key drivers include customizability, enhanced safety, scalability & cost-effectiveness compared to traditional vaccines
-
Competitive landscape features players investing in R&D to optimize VLP candidates and expand product portfolios
-
Challenges like regulatory requirements and manufacturing complexity exist, but innovations in biotech offer opportunities to overcome them